SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is trending after a positive preliminary business update revealed that gross margins are significantly higher than previous guidance due to a favorable product mix. The community is actively discussing the company's record-breaking backlog and debating the potential for a massive short squeeze, with bulls highlighting the strong order volume while bears remain skeptical due to historical concerns over governance and the company's past regulatory history.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is experiencing high volatility as investors weigh strong demand from the AI data center buildout against temporary execution headwinds in the wind segment. Despite recent price pullbacks, the community remains focused on the company's massive order backlog and strategic position in power grid infrastructure.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T is seeing increased investor scrutiny as market participants weigh robust fiber and fixed wireless growth against competitive concerns regarding SpaceX's Starlink. While the community remains divided over the long-term impact of satellite connectivity, many investors are focused on the company's defensive stability, safe-haven status, and consistent dividend yield amid recent price volatility.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet (GOOG/GOOGL) is under pressure as reports of delays to its Gemini 3.5 Pro model spark concerns about the company's ability to maintain pace with key AI rivals. The community is heavily debating whether this setback justifies current selling or presents a buying opportunity, with investor focus sharply fixed on the stock's massive AI capital expenditure requirements ahead of its impending earnings report.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors digest the formalization of a multi-year partnership with Virgin Atlantic to launch electric air taxi services in the UK, alongside active community discussions regarding its manufacturing joint venture with Toyota. While enthusiasts highlight these strategic milestones as critical steps toward commercial certification, traders remain focused on elevated short interest and technical price volatility as the stock balances between these long-term growth catalysts and near-term market pressure.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending as investors focus on its strong RNAi pipeline and clinical catalysts, including upcoming Phase 3 data, while actively discussing the company's long-term commercial potential and speculative interest in potential M&A activity within the biotech sector.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit Inc. is trending as the community debates a potential move to block Google's crawler to gain leverage in upcoming AI data licensing negotiations. Traders are actively discussing the stock's volatility and its sensitivity to broader AI and software market rotations as they eye upcoming earnings.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is currently the focus of intense investor attention ahead of an upcoming ASCO plenary presentation where clinical data on ivonescimab is expected to be a major catalyst. The community is sharply divided between bullish long-term holders, who are citing heavy insider accumulation and the potential for a breakthrough lung cancer treatment, and skeptical traders focused on regulatory hurdles and competitive market pressures.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is trending after releasing a record-breaking earnings report that highlighted significant revenue growth and progress in reaching profitability in Mexico, though the stock faced volatility as investors scrutinized rising credit costs and loan loss provisions. The community remains divided, with long-term investors highlighting the firm's expanding digital banking ecosystem and AI-driven efficiency as a buy-the-dip opportunity, while others express frustration over persistent downward price pressure and uncertainty regarding future credit quality.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

Alphabet is trending as investors react to reports of a development delay for the Gemini 3.5 Pro model, with the community actively debating whether this signals a broader execution struggle or an overreaction to a temporary setback. Sentiment remains polarized, as many view the current pullback as a prime accumulation opportunity ahead of upcoming earnings, while others worry that rising AI capital expenditures and cooling growth momentum could pressure the stock further.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$APOLLOHOSP.NSE Consolidated Q4FY25 Results and Technical Outlook 

Apollo Hospitals has delivered a resilient consolidated performance in the March and FY25 quarters, supported by consistent topline and margin improvements. For Q4FY25, revenue stood at ₹5,592 Cr, up from ₹5,527 Cr in Q3 and ₹4,944 Cr in Q4FY24, showing a YoY growth of 13.1%. 

Operating profit came in at ₹770 Cr vs ₹762 Cr in Q3 and ₹640 Cr in Q4FY24, with OPM holding at 14%, which is a notable expansion from 13% a year ago. Net profit rose to ₹414 Cr compared to ₹379 Cr in Q3 and ₹258 Cr in Q4FY24, with EPS increasing to ₹27.10 from ₹25.89 sequentially and ₹17.65 YoY. 

On a full-year basis, FY25 revenue touched ₹21,794 Cr, up from ₹19,059 Cr in FY24 and ₹16,612 Cr in FY23, translating to a 14.3% YoY growth. Operating profit expanded to ₹3,022 Cr (vs ₹2,394 Cr in FY24 and ₹2,065 Cr in FY23), improving OPM to 14%. 

Net profit surged to ₹1,505 Cr from ₹935 Cr in FY24 and ₹844 Cr in FY23, driving EPS to ₹100.56 from ₹62.50 last year. While profitability is improving steadily with better operating leverage and cost control, it’s worth noting that tax rates and depreciation have also moderated YoY, further supporting bottom-line growth. 

Overall, Apollo’s consolidated results reflect a solid growth trajectory backed by operational efficiency and digital health investments, though near-term margin volatility may persist in a competitive landscape.

Technical Analysis

Apollo Hospitals is showing a neutral to slightly bearish bias in the near term based on both the daily and weekly charts. On the daily chart, the stock is currently trading at ₹6,880.80, slightly below its 9-day EMA (₹6,982.78), 70-day EMA (₹6,672.05), and 100-day EMA (₹6,728.96), indicating weakening short-term momentum. The price has recently faced rejection from the strong resistance zone near ₹7,125–₹7,200 and is heading towards the ₹6,544–₹6,625 support band, with RSI around 46.53 showing mild bearish momentum. 

On the weekly chart, the stock has formed a bearish candle rejecting the ₹7,125 resistance again, with the RSI at 52.3 suggesting loss of bullish strength without being oversold. The 100-week EMA at ₹6,222.68 is a crucial medium-term support if the current support breaks. Volume is also slightly elevated on the recent red candles, indicating distribution. If the price closes below ₹6,625–₹6,544 support zone in the coming days, it may test ₹6,313 and even ₹6,003. On the upside, only a strong breakout and close above ₹7,125 with volume will revive bullish momentum. Hence, caution is advised for long positions, while short-term traders may watch for breakdown or bounce confirmation from the support zones.

I have attached the daily and weekly chart of $APOLLOHOSP.NSE for your reference.

Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.

Harika Enjamuri

Bala Yogesh

Stocktwits India

$APOLLOHOSP.NSE up 3% till now 🔼 But not all in well in the charts? 👀 @HarikaEnjamuri_SEBI_RA with her detailed insight into the stock 👇

StockTwits Web

StockTwits For Android 

Apollo Hospitals Enterprises Ltd.

 Consolidated Q4FY25 Results and Technical Outlook 

Apollo Hospitals has delivered a resilient consolidated performance in the March and FY25 quarters, supported by consistent topline and margin improvements. For Q4FY25, revenue stood at ₹5,592 Cr, up from ₹5,527 Cr in Q3 and ₹4,944 Cr in Q4FY24, showing a YoY growth of 13.1%. 

Operating profit came in at ₹770 Cr vs ₹762 Cr in Q3 and ₹640 Cr in Q4FY24, with OPM holding at 14%, which is a notable expansion from 13% a year ago. Net profit rose to ₹414 Cr compared to ₹379 Cr in Q3 and ₹258 Cr in Q4FY24, with EPS increasing to ₹27.10 from ₹25.89 sequentially and ₹17.65 YoY. 

On a full-year basis, FY25 revenue touched ₹21,794 Cr, up from ₹19,059 Cr in FY24 and ₹16,612 Cr in FY23, translating to a 14.3% YoY growth. Operating profit expanded to ₹3,022 Cr (vs ₹2,394 Cr in FY24 and ₹2,065 Cr in FY23), improving OPM to 14%. 

Net profit surged to ₹1,505 Cr from ₹935 Cr in FY24 and ₹844 Cr in FY23, driving EPS to ₹100.56 from ₹62.50 last year. While profitability is improving steadily with better operating leverage and cost control, it’s worth noting that tax rates and depreciation have also moderated YoY, further supporting bottom-line growth. 

Overall, Apollo’s consolidated results reflect a solid growth trajectory backed by operational efficiency and digital health investments, though near-term margin volatility may persist in a competitive landscape.

Technical Analysis

Apollo Hospitals is showing a neutral to slightly bearish bias in the near term based on both the daily and weekly charts. On the daily chart, the stock is currently trading at ₹6,880.80, slightly below its 9-day EMA (₹6,982.78), 70-day EMA (₹6,672.05), and 100-day EMA (₹6,728.96), indicating weakening short-term momentum. The price has recently faced rejection from the strong resistance zone near ₹7,125–₹7,200 and is heading towards the ₹6,544–₹6,625 support band, with RSI around 46.53 showing mild bearish momentum. 

On the weekly chart, the stock has formed a bearish candle rejecting the ₹7,125 resistance again, with the RSI at 52.3 suggesting loss of bullish strength without being oversold. The 100-week EMA at ₹6,222.68 is a crucial medium-term support if the current support breaks. Volume is also slightly elevated on the recent red candles, indicating distribution. If the price closes below ₹6,625–₹6,544 support zone in the coming days, it may test ₹6,313 and even ₹6,003. On the upside, only a strong breakout and close above ₹7,125 with volume will revive bullish momentum. Hence, caution is advised for long positions, while short-term traders may watch for breakdown or bounce confirmation from the support zones.

I have attached the daily and weekly chart of 

 for your reference.

Disclaimer: This post is for informational purposes only and not a recommendation to buy or sell any securities. I, or my family, associates, or relatives, may have a financial interest in the securities mentioned.

This account has been verified as a SEBI Research Analyst (RA).